Lyophilization Services for Biopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028
Lyophilization has been popularly employed by the pharmaceuticals industry in parenteral product development. The process has the potential to improve the shelf-life, increase the efficacy of formulations, especially complex injectables, and to make them easier to store and transport. Biopharmaceutical companies adopt lyophilization services for manufacturing sterile lyophilized bulk APIs and drug products. They are gaining popularity for complex biologics. The drive for the lyophilization services for biopharmaceuticals market stems from the inclination and efforts by the industry world over to comply with good manufacturing practices (cGMP).
Various service types can be grouped into product and cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services.
The need for prolonging the shelf-life of antibiotics and protein-based drug formulations is a key trend bolstering the prospect in the lyophilization services for biopharmaceuticals market. Notably, there is a persistent need to keep the biological activity of vaccines intact and the shelf-life as high as possible. The growing uptake of these in third-world countries accentuates the need. Contract manufacturing organizations have also expanded their array of lyophilization services for biopharmaceuticals. This has also expanded the outlook of the lyophilization services for biopharmaceuticals market.
Moreover, technological advances in cGMP lyophilizers have led them to assess cutting-edge lyophilizers at cost-effective rate. The uptake in the lyophilization services for biopharmaceuticals market has been underpinned by the rapid pace of the increasing demand for biological therapies for disease therapeutics in developed as well as developing regions. Over the past few years, the need for improving the shelf-life and efficacy of biologics has been substantial in emerging markets for the biopharmaceutical industry. The drive stems from the need for novel formulations for biologics in developed countries. This has propelled the demand for lyophilization services on contract basis. Automation in lyophilization has bolstered the demands for these services for topical and injectable ophthalmics over the past recent years.
Top players who want to consolidate their hold over the global lyophilization services for biopharmaceuticals market are entering into licensing agreements with their client companies. Apart from this, the strategic moves include acquisitions with the aim of expanding the manufacturing capacity both across key markets as well as in new geographies. Moreover, they are striving to adopt cutting-edge freezing methods in their units.
In recent times, a number of players have leveraged the potential of partnership to expand their new fill and finish equipment for processing sterile packaging. A case in point is West Pharmaceutical Services, Inc., a company that says it pioneers in injectable drug administration solutions, which is entering into a partnership with SCHOTT. The agreement will combine Ready Pack system of the former with the glass vials platform of the later, notably its high-quality RTU glass vials. Numerous such players are aiming to meet the customization needs through partnerships.
Some of the well-entrenched players in the lyophilization services for biopharmaceuticals market are Quality BioResources, Lyophilization Technology, LSNE Contract Manufacturing, Emergent BioSolutions Berkshire Sterile Manufacturing, Axcellerate Pharma, and Anteco Pharma.
Developed countries, such as in North America, have been at the forefront of the lyophilization services for biopharmaceuticals market. The growth of the North America market especially has been fueled by the growing body of research on biologics and protein-based therapeutics. Other developed regions are also growing in prospects in the lyophilization services for biopharmaceuticals market from the rising streams of investment in contract manufacturing services in vaccine development. Moreover, the growing regulatory approval of biologics in developing regions will offer a marked impetus in the near future.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report